参考文献/References:
[1]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:A Cancer Journal for Clinicians,2018,68(6):394-424. [2]Rawla P,Barsouk A.Epidemiology of gastric cancer:global trends, risk factors and prevention[J].Prz Gastroenterol,2019,14(1):26-38. [3]Song Z,Wu Y,Yang J,et al.Progress in the treatment of advanced gastric cancer[J].Tumour Biol,2017,39(7):1010428317714626. [4]Katai H,Ishikawa T,Akazawa K,et al.Five-year survival analysis of surgically resected gastric cancer cases in Japan:a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association(2001-2007)[J].Gastric Cancer,2018,21(1):144-154. [5]Banks M,Graham D,Jansen M,et al.British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma[J].Gut,2019,68(9):1545-1575. [6]Russo AE,Strong VE.Gastric Cancer Etiology and Management in Asia and the West[J].Annu Rev Med,2019(70):353-367. [7]宋玲莉,吴志轩,谷和林.胃蛋白酶原检测联合放大染色内镜检查在胃癌早期筛查中的应用研究[J].现代医药卫生,2020,36(15):2357-2359,2362. [8]杜奕奇,蔡全才,廖专,等.中国早期胃癌筛查流程专家共识意见(草案)(2017年,上海)[J].胃肠病学,2018,23(2):92-97. [9]马颖才,王亚平,刘芝兰,等.血清学检测联合胃镜检查在青海胃癌高发地区早期胃癌筛查中的价值研究[J].中华消化内镜杂志,2020(2):88-93. [10]Ahadi A.Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression[J].IUBMB Life,2020,72(5):884-898. [11]Leung WK,Wu MS,Kakugawa Y,et al.Screening for gastric cancer in Asia:current evidence and practice[J].The Lancet Oncology,2008,9(3):279-287. [12]Fang X,Wen J,Sun M,et al.CircRNAs and its relationship with gastric cancer[J].J Cancer,2019,10(24):6105-6113. [13]于同波,刘程,周珍娟.血清CEA、CA125、CA199及血浆M2-PK联合检测胃癌的诊断价值研究[J].中国实用医药,2018,13(24):3-5. [14]Montagnana M,Danese E.Red cell distribution width and cancer[J].Ann Transl Med,2016,4(20):399. [15]Cheng S,Han F,Wang Y,et al.The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer[J].BMC Gastroenterol,2017,17(1):163. [16]Zhou D,Wu Y,Lin Z,et al.Prognostic Value of Combination of Pretreatment Red Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio in Patients with Gastric Cancer[J].Gastroenterol Res Pract,2018(2018):8042838. [17]May JE,Marques MB,Reddy VVB,et al.Three neglected numbers in the CBC:The RDW,MPV,and NRBC count[J].Cleve Clin J Med,2019,86(3):167-172. [18]Salvagno GL,Sanchis-Gomar F,Picanza A,et al.Red blood cell distribution width:A simple parameter with multiple clinical applications[J].Crit Rev Clin Lab Sci,2015,52(2):86-105. [19]de Gonzalo-Calvo D,de Luxan-Delgado B,Rodriguez-Gonzalez S,et al.Interleukin 6,soluble tumor necrosis factor receptor I and red blood cell distribution width as biological markers of functional dependence in an elderly population:a translational approach[J].Cytokine,2012,58(2):193-198. [20]Pietrzyk L,Plewa Z,Denisow-Pietrzyk M,et al.Diagnostic Power of Blood Parameters as Screening Markers in Gastric Cancer Patients[J].Asian Pac J Cancer Prev,2016,17(9):4433-4437. [21]Wu J,Yang Y,Cheng L,et al.GCdiscrimination:identification of gastric cancer based on a milliliter of blood[J].Brief Bioinform,2020. [22]Choi Y,Kim JW,Nam KH,et al.Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer[J].Gastric Cancer,2017,20(4):602-611. [23]Karki R,Man SM,Kanneganti TD.Inflammasomes and Cancer[J].Cancer Immunology Research,2017,5(2):94-99. [24]Cao X,Xu J.Insights into inflammasome and its research advances in cancer[J].Tumori,2019,105(6):456-464. [25]Jiang Y,Xu H,Jiang H,et al.Pretreatment neutrophil-lymphocyte count ratio may associate with gastric cancer presence[J].Cancer Biomark,2016,16(4):523-528. [26]Wu Y,Jiang M,Qin Y,et al.Single and combined use of neutrophil-lymphocyte ratio,platelet-lymphocyte ratio and carcinoembryonic antigen in diagnosing gastric cancer[J].Clin Chim Acta,2018(481):20-24. [27]卢仁泉,陈苗苗,郭林.肿瘤标志物联合检测及评分模型在肿瘤诊疗中的应用[J].中华检验医学杂志,2018,41(3):180-184. [28]吴娟,郑丹,阮丽蒽,等.多项肿瘤标志物联合检测在胃肠道肿瘤诊断中的价值[J].标记免疫分析与临床,2020,27(1):10-14,18.
相似文献/References:
[1]张凯新,杨林瀛.不同嗜酸性粒细胞水平的慢性阻塞性肺疾病急性加重期患者临床分析[J].医学信息,2021,34(08):85.[doi:10.3969/j.issn.1006-1959.2021.08.022]
ZHANG Kai-xin,YANG Lin-ying.Clinical Analysis of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Different Levels of Eosinophils[J].Medical Information,2021,34(08):85.[doi:10.3969/j.issn.1006-1959.2021.08.022]
[2]董圆振,夏 昆,吴云虎.颅内动脉瘤患者血NLR变化特点及其与Hunt-Hess评分的相关性分析[J].医学信息,2022,35(08):101.[doi:10.3969/j.issn.1006-1959.2022.08.024]
DONG Yuan-zhen,XIA Kun,WU Yun-hu.The Characteristics of Neutrophil to Lymphocyte Ratio Changes in Patients with Intracranial Aneurysm and its Correlation with Hunt-Hess Score[J].Medical Information,2022,35(08):101.[doi:10.3969/j.issn.1006-1959.2022.08.024]
[3]刘 杰,贾 志.NLR、RBP-4及MPV与不稳定型心绞痛患者冠状动脉病变程度的相关性分析[J].医学信息,2022,35(03):91.[doi:10.3969/j.issn.1006-1959.2022.03.021]
LIU Jie,JIA Zhi.Correlation Analysis of NLR, RBP-4 and MPV with Coronary Artery Lesionsin Patients with Unstable Angina Pectoris[J].Medical Information,2022,35(08):91.[doi:10.3969/j.issn.1006-1959.2022.03.021]
[4]李安乐,戴 夫,彭 琼.中性粒细胞与淋巴细胞比值、红细胞体积分布宽度与乙型肝炎及乙型肝炎肝硬化的关系研究[J].医学信息,2019,32(03):69.[doi:10.3969/j.issn.1006-1959.2019.03.022]
LI An-le,DAI Fu,PENG Qiong.Relationship between Neutrophil-lymphocyte Ratio,Red Blood Cell Volume Distribution Width and Hepatitis B and Hepatitis B Cirrhosis[J].Medical Information,2019,32(08):69.[doi:10.3969/j.issn.1006-1959.2019.03.022]